Cargando…

Development of an Adult Physiologically Based Pharmacokinetic Model of Solithromycin in Plasma and Epithelial Lining Fluid

Solithromycin is a fluoroketolide antibiotic under investigation for community‐acquired bacterial pneumonia (CABP). We developed a whole‐body physiologically based pharmacokinetic (PBPK) model for solithromycin in adults using PK‐Sim and MoBi version 6.2, which incorporated time‐dependent CYP3A4 aut...

Descripción completa

Detalles Bibliográficos
Autores principales:	Salerno, Sara N., Edginton, Andrea, Cohen‐Wolkowiez, Michael, Hornik, Christoph P., Watt, Kevin M., Jamieson, Brian D., Gonzalez, Daniel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2017
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5744174/ https://www.ncbi.nlm.nih.gov/pubmed/29068158 http://dx.doi.org/10.1002/psp4.12252

Ejemplares similares

Physiologically‐Based Pharmacokinetic Modeling of Fluconazole Using Plasma and Cerebrospinal Fluid Samples From Preterm and Term Infants
por: Gerhart, Jacqueline G., et al.
Publicado: (2019)

Physiologically Based Pharmacokinetic Approach to Determine Dosing on Extracorporeal Life Support: Fluconazole in Children on ECMO
por: Watt, Kevin M., et al.
Publicado: (2018)

Development and Evaluation of a Virtual Population of Children with Obesity for Physiologically Based Pharmacokinetic Modeling
por: Gerhart, Jacqueline G., et al.
Publicado: (2021)

In Vitro Activity of Solithromycin against Bordetella pertussis, an Emerging Respiratory Pathogen
por: Hardy, Dwight J., et al.
Publicado: (2016)

Population Pharmacokinetic/Pharmacodynamic Modeling of Methylprednisolone in Neonates Undergoing Cardiopulmonary Bypass
por: Hornik, Christoph P., et al.
Publicado: (2019)

Physiologically-Based Pharmacokinetic Modeling Characterizes the CYP3A-Mediated Drug-Drug Interaction Between Fluconazole and Sildenafil in Infants
por: Salerno, Sara N., et al.
Publicado: (2020)

Spotlight on solithromycin in the treatment of community-acquired bacterial pneumonia: design, development, and potential place in therapy
por: Donald, Bryan J, et al.
Publicado: (2017)

Estimation of Body Fat Percentage for Clinical Pharmacokinetic Studies in Children
por: Green, Thomas P., et al.
Publicado: (2020)

Pharmacokinetics of doripenem in plasma and epithelial lining fluid (ELF): comparison of two dosage regimens
por: Oesterreicher, Zoe, et al.
Publicado: (2017)

Population Pharmacokinetic Modelling of Ceftazidime and Avibactam in the Plasma and Epithelial Lining Fluid of Healthy Volunteers
por: Dimelow, Richard, et al.
Publicado: (2018)

Pharmacokinetics of hydroxychloroquine in paediatric lupus: data from a novel, direct-to-family clinical trial
por: Balevic, Stephen J, et al.
Publicado: (2022)

A New, Potent, and Placenta-Permeable Macrolide Antibiotic, Solithromycin, for the Prevention and Treatment of Bacterial Infections in Pregnancy
por: Keelan, Jeffrey A., et al.
Publicado: (2016)

Solithromycin inhibits IL-13-induced goblet cell hyperplasia and MUC5AC, CLCA1, and ANO1 in human bronchial epithelial cells
por: Kimura, Yasuhiro, et al.
Publicado: (2023)

Use of Real‐World Data and Physiologically‐Based Pharmacokinetic Modeling to Characterize Enoxaparin Disposition in Children With Obesity
por: Gerhart, Jacqueline G., et al.
Publicado: (2022)

Physiologically‐Based Pharmacokinetic Modeling vs. Allometric Scaling for the Prediction of Infliximab Pharmacokinetics in Pediatric Patients
por: Malik, Paul R. V., et al.
Publicado: (2019)

Using Physiologically Based Pharmacokinetic Modeling for Mechanistic Insight: Cases of Reverse Translation
por: Edginton, Andrea N.
Publicado: (2017)

Comparison of Omadacycline and Tigecycline Pharmacokinetics in the Plasma, Epithelial Lining Fluid, and Alveolar Cells of Healthy Adult Subjects
por: Gotfried, Mark H., et al.
Publicado: (2017)

Physiologically Based Pharmacokinetic Modeling and Simulation in Pediatric Drug Development
por: Maharaj, A R, et al.
Publicado: (2014)

Population Pharmacokinetic Analysis for Plasma and Epithelial Lining Fluid Ceftolozane/Tazobactam Concentrations in Patients With Ventilated Nosocomial Pneumonia
por: Zhang, Zufei, et al.
Publicado: (2020)

Population Pharmacokinetics of Metoclopramide in Infants, Children, and Adolescents
por: Ge, Shufan, et al.
Publicado: (2020)

Staphylococcus aureus with an erm-mediated constitutive macrolide-lincosamide-streptogramin B resistance phenotype has reduced susceptibility to the new ketolide, solithromycin
por: Yao, Weiming, et al.
Publicado: (2019)

Population Pharmacokinetics and Exploratory Exposure‐Response Relationships of Diazepam in Children Treated for Status Epilepticus
por: Ku, Lawrence C., et al.
Publicado: (2018)

625. SPR206 Pharmacokinetics (PK) in Plasma, Epithelial Lining Fluid (ELF), and Alveolar Macrophages (AM) in Healthy Adult Subjects
por: Rodvold, Keith A, et al.
Publicado: (2022)

Pharmacokinetics of SPR206 in Plasma, Pulmonary Epithelial Lining Fluid, and Alveolar Macrophages following Intravenous Administration to Healthy Adult Subjects
por: Rodvold, Keith A., et al.
Publicado: (2023)

Pharmacokinetics Alterations in Critically Ill Pediatric Patients on Extracorporeal Membrane Oxygenation: A Systematic Review
por: Sutiman, Natalia, et al.
Publicado: (2020)

Use of physiologically‐based pharmacokinetic modeling to inform dosing of the opioid analgesics fentanyl and methadone in children with obesity
por: Gerhart, Jacqueline G., et al.
Publicado: (2022)

Population physiologically-based pharmacokinetic model incorporating lymphatic uptake for a subcutaneously administered pegylated peptide
por: Offman, Elliot, et al.
Publicado: (2016)

Predicting Resolvin D1 Pharmacokinetics in Humans with Physiologically‐Based Pharmacokinetic Modeling
por: Yellepeddi, Venkata K., et al.
Publicado: (2020)

Characterizing Pharmacokinetics in Children With Obesity—Physiological, Drug, Patient, and Methodological Considerations
por: Gerhart, Jacqueline G., et al.
Publicado: (2022)

Epithelial lining fluid analysis
por: Ishizaka, A
Publicado: (2005)

Quantifying breast milk intake by term and preterm infants for input into paediatric physiologically based pharmacokinetic models
por: Yeung, Cindy H.T., et al.
Publicado: (2020)

Delivering clinical trials at home: protocol, design and implementation of a direct-to-family paediatric lupus trial
por: Randell, Rachel L, et al.
Publicado: (2021)

Dynamically simulating the interaction of midazolam and the CYP3A4 inhibitor itraconazole using individual coupled whole-body physiologically-based pharmacokinetic (WB-PBPK) models
por: Vossen, Michaela, et al.
Publicado: (2007)

1302. Cefiderocol Population Pharmacokinetics and Probability of Target Attainment in Plasma and Epithelial Lining Fluid in Patients with Pneumonia, Bloodstream Infection/Sepsis, or Complicated Urinary Tract Infections
por: Katsube, Takayuki, et al.
Publicado: (2020)

Verifying in vitro‐determined enzyme contributions to cannabidiol clearance for exposure predictions in human through physiologically‐based pharmacokinetic modeling
por: Yeung, Cindy H. T., et al.
Publicado: (2023)

Cefazolin Pharmacokinetics in Premature Infants
por: Balevic, Stephen J., et al.
Publicado: (2019)

Biodistribution and Physiologically-Based Pharmacokinetic Modeling of Gold Nanoparticles in Mice with Interspecies Extrapolation
por: Aborig, Mohamed, et al.
Publicado: (2019)

Development of a population pharmacokinetic model to characterize the pharmacokinetics of intrathecally administered tominersen in cerebrospinal fluid and plasma
por: Yamamoto, Yumi, et al.
Publicado: (2023)

Physiologically‐based pharmacokinetic modeling of immunoglobulin and antibody coadministration in patients with primary human immunodeficiency
por: Salerno, Sara N., et al.
Publicado: (2022)

A point-of-care pharmacokinetic/pharmacodynamic trial in critically ill children: Study design and feasibility
por: Thompson, Elizabeth J., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_vck17ug3fs44jp7869q8jk76nd